Queen's Award Received in 2021 ISO 9001 Certified Delivered over 1,000,000 bio-reagents to life science researchers Trusted by Life Science Communities
Cart summary

You have no items in your shopping cart.

Vinblastine

SKU: orb1685623

Description

Vinblastine is a microtubule-disrupting agent that also inhibits nicotinic acetylcholine receptor (nAChR) activity with an IC50 of 8.9 µM. It is widely used in cancer research, particularly for studying mitotic arrest and apoptosis in both in vitro cell cultures and in vivo tumor models.

Research Area

Neuroscience, Pharmacology & Drug Discovery, Signal Transduction

Images & Validation

Key Properties

CAS Number865-21-4
MW810.97
Purity97.42% (May vary between batches)
FormulaC46H58N4O9
SMILES[H][C@@]12N3CC[C@@]11c4cc(c(OC)cc4N(C)[C@@]1([H])[C@](O)([C@H](OC(C)=O)[C@]2(CC)C=CC3)C(=O)OC)[C@]1(C[C@@]2([H])CN(C[C@](O)(CC)C2)CCc2c1[nH]c1ccccc21)C(=O)OC
TargetMicrotubule Associated,AChR
SolubilityDMSO:42 mg/mL (51.79 mM);Ethanol:6 mg/mL (7.4 mM)

Bioactivity

Target IC50
nAChR:8.9 μM
In Vivo
Vinblastine is a widely used anticancer drug with undesired side effects. Its conjugation with carrier molecules could be an efficient strategy to reduce these side effects.
In Vitro
Vinblastine does not depolymerize spindle microtubules, yet it powerfully blocks mitosis (for example, IC50 0.8 nM in HeLa cells) and cells die by apoptosis. In NB4 cells, vinblastine produces alteration of p53 and DNA fragmentation. Vinblastine treatment has an antiproliferative effect via the induction of apoptosis producing Bax/Bcl-2 imbalance. Vinblastine treatment suppresses NFκB expression and depresses NFκB-DNA binding activity while maintaining JNK activation that subsequently results in apoptotic response through caspase-dependent pathway. Vinblastine is found to trigger apoptosis as evidenced by the loss of mitochondrial membrane potential, the release of both cytochrome c and apoptosis inducing factor, activation of caspase-9 and 3, and cleavage of Poly (ADP-ribose)-Polymerase.
Cell Research
Six-well treatment plates are set up that contained 5 × 104 cells/mL in each well, suspended in 3 mL culture medium, and these are treated with vinblastine for 3 h followed by 21 h growth. (Only for Reference)

Storage & Handling

Storage-20°C
Expiration Date12 months from date of receipt.
DisclaimerFor research use only

Alternative Names

Vinblastine, nAChR, Microtubule Associated, MicrotubuleAssociated

Similar Products

  • Vinblastine Sulfate [orb746831]

    ≥96%

    143-67-9

    909.07

    C46H58N4O9S H2SO4

    5 mg, 10 mg, 25 mg
  • Polyoxyethylene 40 stearate [orb611689]

    >98%

    9004-99-3

    328.5298

    C20H40O3

    1 g, 250 mg, 100 mg
  • ALB-109564 dihydrochloride [orb1702602]

    1300114-12-8

    929.99

    C47H62Cl2N4O9S

    25 mg
  • A 30312 [orb1701391]

    144092-65-9

    328.84

    C19H21ClN2O

    50 mg, 100 mg, 25 mg
  • EC0489 [orb1707972]

    1096702-14-5

    2550.7

    C111H156N22O43S2

    25 mg, 100 mg, 50 mg
Quality Guarantee

Quality Guarantee

Explore bioreagents carefree to elevate your research. All our products are rigorously tested for performance. If a product does not perform as described on its datasheet, our scientific support team will provide expert troubleshooting, a prompt replacement, or a refund. For full details, please see our Terms & Conditions and Buying Guide. Contact us at support@biorbyt.com.

Key Properties

No computed properties available.

Protocol Information

Available Sizes

Select a size below

20 mg
$ 440.00
DispatchUsually dispatched within 5-10 working days
Bulk Enquiry